Vertex’s non-opioid pill disappoints in mid-stage chronic pain study

Vertex Pharmaceuticals announced highly anticipated results from a Phase 2 trial Thursday morning in a chronic pain condition, saying its non-opioid pain pill suzetrigine met the primary endpoint and that it ...